• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    2024 Entrepreneurship Summit Presented by the Harvard Undergraduate Venture Capital Group: Agenda and Speakers

    3/22/24 6:14:00 PM ET
    $BEAM
    $DASH
    $LYFT
    $AVEO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    EDP Services
    Technology
    Get the next $BEAM alert in real time by email

    The Harvard Undergraduate Venture Capital Group (VCG) will hold its annual Entrepreneurship Summit on Sunday, March 24, 2024, from 8 AM to 5:30 PM at The Ritz-Carlton in Boston. The Summit is the largest undergraduate entrepreneurship and venture capital conference in the nation and will bring together founders of unicorn startups, CEOs of public companies, and renowned venture capital and private equity investors.

    The event will convene over 55 speakers and 15 panels on Leadership, Investing, and Entrepreneurship with Advanced Tracks discussing topics ranging from biotech to investing in AI.

    Keynote speakers include:

    • Steve Kraus, Partner at Bessemer Venture Partners and world-renowned healthcare investor. He invested in Sirtris Pharmaceuticals (NASDAQ:SIRT); Affymax (NASDAQ:AFFY); Aveo (NASDAQ:AVEO); Alnara, acquired by Eli Lilly; and many more.
    • John Evans, CEO of Beam Therapeutics (NASDAQ:BEAM), leading biotechnology company in gene therapies with a market capitalization of $2.85 billion.
      • Fireside chat with Steve Knight, President and Managing Partner of F-Prime Capital, top VC firm in healthcare and technology with $2+ billion AUM.
    • Tim Westergren, Founder and Former CEO of Pandora (NYSE:P), the music streaming service with a market capitalization of over $100 billion. He most recently founded HelloCreator, an AI-based application to help creators navigate their careers.
    • Earl Jones, Partner at DCVC, deep tech VC firm with over $2.6 billion AUM, and Alex Rappaport, Founder and CEO of ZwitterCo, a company that develops membranes that reuses the world's toughest wastewaters.

    Advanced Track session speakers feature:

    • Nick Sinai, Senior Advisor at Insight Partners, former White House U.S. Deputy Chief Technology Officer, and former presidential cabinet member under Obama.
    • James Currier, Founder of NFX, a $1.6B venture capital firm focused on network effect businesses. He invested in Doordash (NASDAQ:DASH), Lyft (NASDAQ:LYFT), Poshmark (MCAP: $1.42B), and more.
    • Bryce Youngren, Managing Partner at Polaris Growth Fund, a dedicated growth buyout firm with over $5.5 billion in assets under management.

    "For this year's Entrepreneurship Summit, we are excited to build off of the momentum of last year's leadership and take it to new heights. We're looking forward to gathering the next generation of entrepreneurs under one roof for a full day of community building," said Nick Apostolicas, President of VCG.

    VCG gratefully acknowledges everyone who made this extraordinary event possible. Special thanks to our PLATINUM SPONSOR, DCVC; our GOLD SPONSOR, Graphene Ventures; our SILVER SPONSORS, F-Prime Capital, Third Rock Ventures, Lemann Program on Creativity and Entrepreneurship (LPCE), and Forum Ventures; and our BRONZE SPONSORS, Insight Partners, Blumberg Capital, Clearvision Ventures, Xfund, Octonic VR, senhasegura, WakeCap Technologies, and Boston College High School Jack Shields Center for Innovation.

    To purchase summit tickets, visit harvardvcg2024entrepreneurshipsummit.eventbrite.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240322999918/en/

    Get the next $BEAM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BEAM
    $DASH
    $LYFT
    $AVEO

    CompanyDatePrice TargetRatingAnalyst
    Lyft Inc.
    $LYFT
    8/7/2025$19.00Neutral → Buy
    Roth Capital
    DoorDash Inc.
    $DASH
    7/15/2025$250.00Hold → Buy
    Jefferies
    DoorDash Inc.
    $DASH
    7/15/2025$250.00Buy → Hold
    Jefferies
    DoorDash Inc.
    $DASH
    7/1/2025$225.00 → $265.00Buy
    BTIG Research
    Lyft Inc.
    $LYFT
    6/24/2025$21.00Hold → Buy
    TD Cowen
    DoorDash Inc.
    $DASH
    6/23/2025$260.00Outperform → Strong Buy
    Raymond James
    DoorDash Inc.
    $DASH
    6/11/2025$198.00Hold
    Stifel
    Lyft Inc.
    $LYFT
    5/9/2025$20.00Neutral → Buy
    Goldman
    More analyst ratings

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lyft Announces Updates to Board of Directors and Enhanced Voting and Governance Structures

    Co-Founders Logan Green and John Zimmer to Step Down from Lyft Board and Convert Class B Shares Sean Aggarwal Elected Board Chair, Maintaining Board Leadership and Enhancing Independence Lyft, Inc. (NASDAQ:LYFT) today announced that its co-founders, Logan Green, Chair of the Board, and John Zimmer, Vice Chair of the Board, intend to step down from the Lyft Board of Directors (the "Board") on August 14, 2025, marking the successful completion of a two-year transition plan. Green and Zimmer will also convert all shares of Lyft Class B common stock to Lyft Class A common stock on August 15, 2025. Following the conversion, all holders of Lyft common stock will hold Class A common stock with

    8/14/25 4:05:00 PM ET
    $LYFT
    Real Estate

    DoorDash and Ace Pickleball Club Announce Multi-Year Partnership to Bring On-Demand Convenience to Club Members Nationwide

    DoorDash integration makes it easier than ever for Ace Pickleball Club members to fuel up and play more. SAN FRANCISCO and ROSWELL, Ga., Aug. 14, 2025 /PRNewswire/ -- DoorDash and Ace Pickleball Club (APC), who specializes in developing indoor pickleball clubs and delivering exceptional member experiences, today announced a strategic multi-year partnership. As part of the agreement, DoorDash becomes the Official On-Demand Delivery & Pickup Platform of Ace Pickleball Club, delivering convenience directly to the courts. Through this partnership, DoorDash will offer exclusive ben

    8/14/25 9:05:00 AM ET
    $DASH
    EDP Services
    Technology

    Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease

    CAMBRIDGE, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BEAM-101, an investigational genetically modified cell therapy for the treatment of sickle cell disease (SCD). "We are thrilled that the FDA has granted RMAT designation to BEAM-101, following orphan drug designation earlier this year, reinforcing its potential as a one-time, best-in-class therapy for severe sickle cell disease," said Giuseppe Ciaramella, Ph.D., pre

    8/14/25 7:00:00 AM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BEAM
    $DASH
    $LYFT
    $AVEO
    SEC Filings

    View All

    SEC Form 144 filed by Lyft Inc.

    144 - Lyft, Inc. (0001759509) (Subject)

    8/20/25 4:23:20 PM ET
    $LYFT
    Real Estate

    Lyft Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Lyft, Inc. (0001759509) (Filer)

    8/14/25 4:10:03 PM ET
    $LYFT
    Real Estate

    SEC Form SCHEDULE 13G filed by Lyft Inc.

    SCHEDULE 13G - Lyft, Inc. (0001759509) (Subject)

    8/14/25 2:31:59 PM ET
    $LYFT
    Real Estate

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Risher John David bought $99,995 worth of shares (6,538 units at $15.29), increasing direct ownership by 0.06% to 11,791,340 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    5/30/25 8:44:19 AM ET
    $LYFT
    Real Estate

    Chief Executive Officer Risher John David bought $250,272 worth of shares (13,790 units at $18.15), increasing direct ownership by 0.11% to 12,112,796 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    11/14/24 4:05:10 PM ET
    $LYFT
    Real Estate

    Chief Executive Officer Risher John David bought $501,025 worth of shares (51,815 units at $9.67), increasing direct ownership by 0.43% to 12,099,006 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    8/13/24 4:07:54 PM ET
    $LYFT
    Real Estate

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Llewellyn Lindsay Catherine covered exercise/tax liability with 32,418 shares and sold $449,301 worth of shares (28,356 units at $15.85), decreasing direct ownership by 7% to 850,388 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    8/22/25 7:10:07 PM ET
    $LYFT
    Real Estate

    CHIEF FINANCIAL OFFICER Brewer Erin covered exercise/tax liability with 180,852 shares, gifted 156,870 shares, received a gift of 156,870 shares and sold $228,566 worth of shares (15,000 units at $15.24), decreasing direct ownership by 20% to 1,315,655 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    8/22/25 7:08:08 PM ET
    $LYFT
    Real Estate

    CHIEF EXECUTIVE OFFICER Xu Tony gifted 80,000 shares, sold $69,408,326 worth of shares (291,403 units at $238.19), disposed of 227,547 shares and acquired 80,000 shares, decreasing direct ownership by 100% to 1,500 units (SEC Form 4)

    4 - DoorDash, Inc. (0001792789) (Issuer)

    8/22/25 4:15:37 PM ET
    $DASH
    EDP Services
    Technology

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lyft upgraded by Roth Capital with a new price target

    Roth Capital upgraded Lyft from Neutral to Buy and set a new price target of $19.00

    8/7/25 7:37:35 AM ET
    $LYFT
    Real Estate

    DoorDash upgraded by Jefferies with a new price target

    Jefferies upgraded DoorDash from Hold to Buy and set a new price target of $250.00

    7/15/25 3:48:27 PM ET
    $DASH
    EDP Services
    Technology

    DoorDash downgraded by Jefferies with a new price target

    Jefferies downgraded DoorDash from Buy to Hold and set a new price target of $250.00

    7/15/25 8:36:16 AM ET
    $DASH
    EDP Services
    Technology

    $BEAM
    $DASH
    $LYFT
    $AVEO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FOTIVDA issued to AVEO PHARMACEUTICALS INC

    Submission status for AVEO PHARMACEUTICALS INC's drug FOTIVDA (ORIG-1) with active ingredient TIVOZANIB HYDROCHLORIDE has changed to 'Approval' on 03/10/2021. Application Category: NDA, Application Number: 212904, Application Classification: Type 1 - New Molecular Entity

    3/29/21 5:44:34 PM ET
    $AVEO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for FOTIVDA

    Submission status for AVEO PHARMACEUTICALS INC's drug FOTIVDA (ORIG-1) with active ingredient TIVOZANIB has changed to 'Approval' on 03/10/2021. Application Category: NDA, Application Number: 212904, Application Classification: Type 1 - New Molecular Entity

    3/10/21 2:49:22 PM ET
    $AVEO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Lyft Inc.

    SC 13G/A - Lyft, Inc. (0001759509) (Subject)

    12/4/24 2:38:58 PM ET
    $LYFT
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Lyft Inc.

    SC 13G/A - Lyft, Inc. (0001759509) (Subject)

    11/12/24 10:32:11 AM ET
    $LYFT
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Beam Therapeutics Inc.

    SC 13G/A - Beam Therapeutics Inc. (0001745999) (Subject)

    11/12/24 9:50:15 AM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Financials

    Live finance-specific insights

    View All

    Lyft to Announce Second Quarter 2025 Financial Results

    Lyft, Inc. (NASDAQ:LYFT) (the "Company" or "Lyft") will release financial results for the second quarter of 2025 after the close of the market on Wednesday, August 6, 2025. On the same day, Lyft will host a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results and business highlights. To listen to the live audio webcast, please visit the Company's Investor Relations page at https://investor.lyft.com/. The archived webcast will be available on the Company's Investor Relations page shortly after the call. Lyft announces material information to the public about the Company, its products and services and other matters through a variety of me

    7/16/25 4:05:00 PM ET
    $LYFT
    Real Estate

    DoorDash to Announce Second Quarter 2025 Financial Results on August 6, 2025

    DoorDash, Inc. (NASDAQ:DASH) today announced that the company's second quarter 2025 financial results will be released after the U.S. financial markets close on Wednesday, August 6, 2025. The company's earnings press release will be made available on the DoorDash Investor Relations website at ir.doordash.com. DoorDash will host a conference call to discuss its results and guidance at 2 p.m. PT / 5 p.m. ET the same day. Interested parties may register for and access the live webcast of the call at the DoorDash Investor Relations website at ir.doordash.com. Following the call, a replay will be available at the same website. DoorDash announces material information to the public about the c

    7/1/25 9:00:00 AM ET
    $DASH
    EDP Services
    Technology

    Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress

    Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Patients Required a Median of One Mobilization Cycle and Experienced Rapid Neutrophil and Platelet Engraftment Safety Profile Remained Consistent with Busulfan Conditioning, Autologous Hematopoietic Stem Cell Transplantation and Underlying SCD Enrollment Complete in Both Adult and Adolescent Cohorts of the BEACON Trial, with 30 Patients Expected to be Dosed by Mid-2025 Beam to Host Investor Webcast Today, June 13, 2025, at 4:00 p.m. ET CAMBRIDGE, Mass., June 13, 2025 (GL

    6/13/25 7:00:00 AM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BEAM
    $DASH
    $LYFT
    $AVEO
    Leadership Updates

    Live Leadership Updates

    View All

    Domino's® and DoorDash Announce Partnership: World's Largest Pizza Company to Join Largest Local Commerce Platform in North America

    Orders on DoorDash's Marketplace will be delivered by Domino's drivers Partnership Highlights: Domino's Joins DoorDash Marketplace: Nationwide U.S. launch beginning in May 2025, expanding to Canada later in 2025Seamless Integration with Self-Delivery: Domino's drivers fulfill orders while tapping into DoorDash's leading local commerce platform for new customer reachANN ARBOR, Mich. and SAN FRANCISCO, April 2, 2025 /PRNewswire/ -- Domino's Pizza Inc. (NASDAQ:DPZ), the largest pizza company in the world, has entered into a partnership with DoorDash (NASDAQ:DASH), the leading local commerce platform in North America.1 The partnership will allow Domino's to reach new customers through DoorDash

    4/2/25 7:07:00 AM ET
    $DASH
    $DPZ
    EDP Services
    Technology
    Food Distributors
    Consumer Discretionary

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

    CAMBRIDGE, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Sravan K. Emany as chief financial officer (CFO), effective December 19, 2024. Mr. Emany brings to Beam a breadth of global operational, commercial and financial experience with multinational public corporations and financial institutions. He most recently served as CFO and chief operating officer at Ironwood Pharmaceuticals, Inc. "Beam has built a strong financial position to advance our portfolio of genetic medicines, and Sravan has an exceptional background to lead our capital fo

    12/6/24 7:00:00 AM ET
    $ASRT
    $BEAM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)